CORCEPT THERAPEUTICS INC (CORT)
Pharmaceutical Preparations
Latest Price
$112.79
TTM P/E
268.55
Normalized P/E
127.59
Div Yield
--
Book Value
6.73
P/B Ratio
16.77
Valuation metrics
adjust assumptions →EPS: $0.82
Book value / share: $6.11
Formula: √(22.5 × EPS × BVPS)
Graham Number
$10.62
91% downside
Norm. op. income: $113M (median of 7yr)
Tax rate: 14%
Discount rate: 10%
Growth assumption: zero (EPV is a no-growth value)
Earnings Power Value
$12.68
89% downside
Base FCF: $142M (median of recent 5yr)
Growth: 8%/yr (median YOY, capped at 25%)
Discount rate: 10%
Terminal growth: 3%
Projection horizon: 10 years
DCF Fair Value
$32.98
71% downside
EPS: $0.82
Target P/E: 15×
Formula: EPS × P/E
P/E Fair Value
$12.30
89% downside
Institutional Ownership
79.7% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 12.43M | $1.08B | 11.85% | +280.7K | 2026-06-30 |
| INGALLS & SNYDER LLC | 7.95M | $690.0M | 7.58% | +335.1K | 2026-06-30 |
| RENAISSANCE TECHNOLOGIES LLC | 5.26M | $457.0M | 5.02% | -421.2K | 2026-06-30 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 5.04M | $438.0M | 4.81% | +224.1K | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.17M | $362.0M | 3.98% | +95.3K | 2026-06-30 |
| Parallel Advisors, LLC | 3.96M | $344.0M | 3.78% | -15.2K | 2026-06-30 |
| FMR LLC | 3.34M | $290.0M | 3.18% | +147.4K | 2026-06-30 |
| STATE STREET CORP | 3.28M | $285.0M | 3.13% | +78.4K | 2026-06-30 |
| AQR CAPITAL MANAGEMENT LLC | 2.58M | $224.0M | 2.46% | +2.18M | 2026-06-30 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.53M | $220.0M | 2.41% | -181.3K | 2026-06-30 |